$OPK
OPKO HEALTH, INC. Stock $opk

$opk Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000094480916000022 Filed on May 09, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$268.9M	$30.08M
YoY Change	793.99%	35.06%
Cost Of Revenue	$137.6M	$10.32M
YoY Change	1233.3%	-16.71%
Gross Profit	$131.4M	$19.76M
YoY Change	564.6%	99.98%
Gross Profit Margin	48.84%	65.7%
Selling, General & Admin	$128.0M	$17.45M
YoY Change	633.7%	26.31%
% of Gross Profit	97.45%	88.27%
Research & Development	$27.82M	$25.50M
YoY Change	9.09%	21.48%
% of Gross Profit	21.18%	129.04%
Depreciation & Amortization	$22.20M	$3.525M
YoY Change	529.76%	-1.09%
% of Gross Profit	16.9%	17.84%
Operating Expenses	$299.7M	$87.00M
YoY Change	244.53%	65.55%
Operating Profit	-$27.52M	-$56.91M
YoY Change	-51.65%	87.98%
Interest Expense	-$3.200M	-$52.30M
YoY Change	-93.88%	273.57%
% of Operating Profit
Other Income/Expense, Net	-$2.621M	-$53.85M
YoY Change	-95.13%	343.45%
Pretax Income	-$30.14M	-$110.8M
YoY Change	-72.79%	161.11%
Income Tax	-$20.51M	$5.509M
% Of Pretax Income
Net Earnings	-$15.25M	-$118.0M
YoY Change	-87.08%	164.95%
Net Earnings / Revenue	-5.67%	-392.36%
Basic Earnings Per Share	-$0.03	-$0.26
Diluted Earnings Per Share	-$0.03	-$0.26
COMMON SHARES
Basic Shares Outstanding	545.7M shares	451.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$175.0M	$348.2M
YoY Change	-49.74%	122.63%
Cash & Equivalents	$175.0M	$348.2M
Short-Term Investments
Other Short-Term Assets	$306.0K	$3.384M
YoY Change	-90.96%	-40.16%
Inventory	$40.58M	$18.32M
Prepaid Expenses
Receivables	$204.5M	$19.06M
Other Receivables	$21.20M	$2.700M
Total Short-Term Assets	$453.5M	$394.0M
YoY Change	15.1%	91.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$133.9M	$15.12M
YoY Change	785.9%	-10.43%
Goodwill	$747.0M	$223.2M
YoY Change	234.63%	-1.26%
Intangibles
YoY Change
Long-Term Investments	$30.60M	$12.70M
YoY Change	140.94%	-56.06%
Other Assets	$4.522M	$5.073M
YoY Change	-10.86%	-22.19%
Total Long-Term Assets	$2.340B	$1.118B
YoY Change	109.23%	-2.8%
TOTAL ASSETS
Total Short-Term Assets	$453.5M	$394.0M
Total Long-Term Assets	$2.340B	$1.118B
Total Assets	$2.793B	$1.512B
YoY Change	84.71%	11.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$73.44M	$10.47M
YoY Change	601.26%	-28.74%
Accrued Expenses	$182.3M	$158.8M
YoY Change	14.85%	170.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$11.45M	$13.60M
YoY Change	-15.8%	23.3%
Total Short-Term Liabilities	$267.2M	$182.8M
YoY Change	46.16%	116.38%
LONG-TERM LIABILITIES
Long-Term Debt	$2.366M	$2.185M
YoY Change	8.28%	-29.54%
Other Long-Term Liabilities	$275.8M	$410.2M
YoY Change	-32.76%	90.65%
Total Long-Term Liabilities	$528.1M	$516.8M
YoY Change	2.18%	17.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$267.2M	$182.8M
Total Long-Term Liabilities	$528.1M	$516.8M
Total Liabilities	$795.3M	$699.7M
YoY Change	13.67%	33.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$716.8M	-$792.0M
YoY Change	-9.48%	44.59%
Common Stock	$5.480M	$4.593M
YoY Change	19.31%	10.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.911M	$4.051M
YoY Change	-52.83%	-44.51%
Treasury Stock Shares	586.8K shares	1.245M shares
Shareholders Equity	$1.998B	$819.9M
YoY Change
Total Liabilities & Shareholders Equity	$2.793B	$1.512B
YoY Change	84.71%	11.55%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$15.25M	-$118.0M
YoY Change	-87.08%	164.95%
Depreciation, Depletion And Amortization	$22.20M	$3.525M
YoY Change	529.76%	-1.09%
Cash From Operating Activities	-$9.206M	$238.8M
YoY Change	-103.86%	-1156.09%
INVESTING ACTIVITIES
Capital Expenditures	-$9.800M	-$400.0K
YoY Change	2350.0%	-55.56%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$300.0K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$10.06M	-$363.0K
YoY Change	2671.9%	37.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$53.00K	$13.81M
YoY Change	-99.62%	-311.48%
NET CHANGE
Cash From Operating Activities	-$9.206M	$238.8M
Cash From Investing Activities	-$10.06M	-$363.0K
Cash From Financing Activities	$53.00K	$13.81M
Net Change In Cash	-$19.22M	$252.2M
YoY Change	-107.62%	-957.79%
FREE CASH FLOW
Cash From Operating Activities	-$9.206M	$238.8M
Capital Expenditures	-$9.800M	-$400.0K
Free Cash Flow	$594.0K	$239.2M
YoY Change	-99.75%	-1201.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000944809
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	547444354	shares
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	Opko Health, Inc.
CY2015Q4	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	2505000	USD
CY2016Q1	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	5850000	USD
CY2016Q1	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent	-1900000	USD
CY2015Q4	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	5000000	USD
CY2016Q1	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	4914000	USD
CY2015Q4	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	2200000	USD
CY2016Q1	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	2200000000	USD
CY2015Q1	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	25900000	USD
CY2015Q1	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	25889000	USD
CY2016Q1	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	0	USD
CY2015Q1	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	14238000	USD
CY2016Q1	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	35000	USD
CY2015Q4	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	10	institution
CY2016Q1	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	9	institution
CY2016Q1	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	22725000	USD
CY2016Q1	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	667000	USD
CY2015Q1	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-116276000	USD
CY2016Q1	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-9633000	USD
CY2015Q1	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	473000	USD
CY2016Q1	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	-253000	USD
CY2015Q1	opk	Interest Expense Nonoperating InterestExpenseNonoperating	2565000	USD
CY2016Q1	opk	Interest Expense Nonoperating InterestExpenseNonoperating	1787000	USD
CY2015Q1	opk	Interest Income Nonoperating InterestIncomeNonoperating	8000	USD
CY2016Q1	opk	Interest Income Nonoperating InterestIncomeNonoperating	43000	USD
CY2016Q1	opk	Numberof Sales Employees NumberofSalesEmployees	420	employee
CY2016Q1	opk	Percentage Of Increase Decrease In Future Sales PercentageOfIncreaseDecreaseInFutureSales	-0.1
CY2015Q4	opk	Prelaunch Inventory PrelaunchInventory	0	USD
CY2016Q1	opk	Prelaunch Inventory PrelaunchInventory	0	USD
CY2015Q1	opk	Revenue From Receipt Of Equity RevenueFromReceiptOfEquity	60000	USD
CY2016Q1	opk	Revenue From Receipt Of Equity RevenueFromReceiptOfEquity	0	USD
CY2015Q1	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	12529000	USD
CY2016Q1	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	18616000	USD
CY2015Q1	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	1206609	shares
CY2016Q1	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	4224	shares
CY2016Q1	opk	Stock Exchange Agreement Stock Received StockExchangeAgreementStockReceived	5000000	USD
CY2016Q1	opk	Stock Exchange Agreement Stock Received Shares StockExchangeAgreementStockReceivedShares	10204082	shares
CY2016Q1	opk	Stock Exchange Agreement Stock Transferred StockExchangeAgreementStockTransferred	5000000	USD
CY2016Q1	opk	Stock Exchange Agreement Stock Transferred Shares StockExchangeAgreementStockTransferredShares	494462	shares
CY2015Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	21735636	shares
CY2016Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	1799299	shares
CY2015Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	20529027	shares
CY2016Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	1795075	shares
CY2016Q1	opk	Stock Optionand Warrant Investments StockOptionandWarrantInvestments	4615000	USD
CY2015Q4	opk	Taxes Recoverable Current TaxesRecoverableCurrent	3076000	USD
CY2016Q1	opk	Taxes Recoverable Current TaxesRecoverableCurrent	6076000	USD
CY2015Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	11946000	USD
CY2016Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	15122000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	72535000	USD
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	73436000	USD
CY2015Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	219043000	USD
CY2016Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	248120000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	193875000	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	204479000	USD
CY2015Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	29751000	USD
CY2016Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	40791000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	7605000	USD
CY2016Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5986000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	167899000	USD
CY2016Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	182342000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1506000	USD
CY2016Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	707000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-22537000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17110000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2705385000	USD
CY2016Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2728264000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25168000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	43641000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	751000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	37000	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2665000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13443000	USD
CY2015Q4	us-gaap	Assets Assets	2799188000	USD
CY2016Q1	us-gaap	Assets Assets	2793206000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	454058000	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	453532000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3615000	USD
CY2016Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	7205000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	904000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1283000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	267000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2162000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2978000	USD
CY2016Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	8084000	USD
CY2016Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	7205000	USD
CY2015Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	5175000	USD
CY2016Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1753000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	54400000	USD
CY2016Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	55900000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	22164000	USD
CY2016Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	21208000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	32258000	USD
CY2016Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	34674000	USD
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	5373000	USD
CY2016Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	5287000	USD
CY2015Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	9285000	USD
CY2016Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	8861000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96907000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	348192000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	193598000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	174973000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	251285000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-18625000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	546188516	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	547980417	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	5462000	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	5480000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-122223000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6551000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-925000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-123148000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6551000	USD
CY2015Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	48986000	USD
CY2016Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	49608000	USD
CY2015Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	8061000	USD
CY2016Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	9939000	USD
CY2015Q1	us-gaap	Cost Of Services CostOfServices	2259000	USD
CY2016Q1	us-gaap	Cost Of Services CostOfServices	137597000	USD
CY2015Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-22244000	USD
CY2016Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	202680000	USD
CY2015Q4	us-gaap	Deferred Revenue DeferredRevenue	232900000	USD
CY2016Q1	us-gaap	Deferred Revenue DeferredRevenue	217900000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	70246000	USD
CY2016Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	74375000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	162634000	USD
CY2016Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	143520000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	226036000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	900000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	8700000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3525000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22199000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2015Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-957000	USD
CY2016Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	590000	USD
CY2016Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	100000	USD
CY2016Q1	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	77200000	USD
CY2016Q1	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	342600000	USD
CY2016Q1	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	84900000	USD
CY2016Q1	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-31300000	USD
CY2016Q1	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	22106000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	59101000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	72727000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	638152000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	625405000	USD
CY2015Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-49788000	USD
CY2016Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1423000	USD
CY2015Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1761000	USD
CY2016Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2345000	USD
CY2015Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	216000	USD
CY2016Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2015Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-321000	USD
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2015Q4	us-gaap	Goodwill Goodwill	743348000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	746961000	USD
CY2016Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	3934000	USD
CY2016Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-321000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-110767000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-30139000	USD
CY2015Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1761000	USD
CY2016Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2345000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5509000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20506000	USD
CY2015Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	227000	USD
CY2016Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1505000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2107000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-349000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-71000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9924000	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4413000	USD
CY2016Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	13126000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	282238000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-17809000	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2390000	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	152000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	509000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1447000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-944000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6883000	USD
CY2015Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	792275000	USD
CY2016Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	793626000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	1568000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	623000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13404000	USD
CY2016Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14790000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	39681000	USD
CY2016Q1	us-gaap	Inventory Net InventoryNet	40575000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3848000	USD
CY2016Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5051000	USD
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1051000	USD
CY2016Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1230000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1215000	USD
CY2016Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1205000	USD
CY2015Q1	us-gaap	Inventory Write Down InventoryWriteDown	200000	USD
CY2016Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2015Q4	us-gaap	Liabilities Liabilities	819394000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	795332000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2799188000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2793206000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	251902000	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	267232000	USD
CY2015Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	567492000	USD
CY2016Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	528100000	USD
CY2015Q4	us-gaap	Line Of Credit LineOfCredit	82668000	USD
CY2016Q1	us-gaap	Line Of Credit LineOfCredit	82780000	USD
CY2016Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	189484000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11468000	USD
CY2016Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	11454000	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2523000	USD
CY2016Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2366000	USD
CY2015Q4	us-gaap	Long Term Investments LongTermInvestments	34716000	USD
CY2016Q1	us-gaap	Long Term Investments LongTermInvestments	35212000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13812000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-363000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10062000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	238793000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9206000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-925000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-117112000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11978000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-53853000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2621000	USD
CY2016Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	86998000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	318555000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-56914000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27518000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23749000	USD
CY2016Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23224000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	903000	USD
CY2016Q1	us-gaap	Other Assets Current OtherAssetsCurrent	306000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4841000	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4522000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	5427000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3852000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6943000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1259000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1516000	USD
CY2015Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	22265000	USD
CY2016Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	20759000	USD
CY2015Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	13663000	USD
CY2016Q1	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	14048000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	292470000	USD
CY2016Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	275812000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1508000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	546000	USD
CY2015Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	1056000	USD
CY2016Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	749000	USD
CY2015Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2016Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	250000	USD
CY2015Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	363000	USD
CY2016Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	9812000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26904000	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	33505000	USD
CY2015Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2206000	USD
CY2016Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1736000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	12712000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2154000	USD
CY2015Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	5158000	USD
CY2016Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	5248000	USD
CY2015Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	791000	USD
CY2016Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-118037000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-11978000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	131798000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	133948000	USD
CY2015Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	USD
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19600000	USD
CY2016Q1	us-gaap	Purchase Obligation PurchaseObligation	27100000	USD
CY2015Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	4849000	USD
CY2016Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	7349000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25503000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27822000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-704871000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-716849000	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	15486000	USD
CY2016Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	19899000	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	30084000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	291037000	USD
CY2015Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2069000	USD
CY2016Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	252522000	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17446000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	128001000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7382000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7400000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	17307000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	17300000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1979794000	USD
CY2016Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1997874000	USD
CY2015Q4	us-gaap	Supplies Supplies	8773000	USD
CY2016Q1	us-gaap	Supplies Supplies	10265000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1120367	shares
CY2016Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	586760	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3645000	USD
CY2016Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1911000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	446480884	shares
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	545823434	shares
CY2016Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000944809-16-000022-index-headers.html	Edgar Link	pending
0000944809-16-000022-index.html	Edgar Link	pending
0000944809-16-000022.txt	Edgar Link	pending
0000944809-16-000022-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
opk-20160331.xml	Edgar Link	completed
opk-20160331.xsd	Edgar Link	pending
opk-20160331_cal.xml	Edgar Link	unprocessable
opk-20160331_def.xml	Edgar Link	unprocessable
opk-20160331_lab.xml	Edgar Link	unprocessable
opk-20160331_pre.xml	Edgar Link	unprocessable
opk-3312016x10q.htm	Edgar Link	pending
opk-3312016xex311.htm	Edgar Link	pending
opk-3312016xex312.htm	Edgar Link	pending
opk-3312016xex321.htm	Edgar Link	pending
opk-3312016xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPK
OPKO HEALTH, INC. Stock $opk

2016 Q1 Form 10-Q Financial Statement

#000094480916000022 Filed on May 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK OPKO HEALTH, INC. Stock $opk

2016 Q1 Form 10-Q Financial Statement

#000094480916000022 Filed on May 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK
OPKO HEALTH, INC. Stock $opk